Source: International Congress 2018 – Role of omics in population studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. de Vries (Groningen, Netherlands), V. Guryev (Groningen, Netherlands), T. De Jong (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), H. Boezen (Groningen, Netherlands), C. Van Diemen (Groningen, Netherlands). DNA-estimated ageing markers are associated with COPD. 1266

Member's Comments

No comment yet.

Related content which might interest you: Is childhood asthma associated with biological aging markers? Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019 TLCO is associated with phenomenological ageing markers in COPD patients of the COSYCONET cohort Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Which markers other than FEV1 reflect disease progression in COPD? Source: Eur Respir J 2004; 24: Suppl. 48, 45s Year: 2004 Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Lipocalin-2: a biomarker potentially associated with predisposition to COPD Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Inflammatory markers in relation to cachexia in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Are biological markers correlated with nutritional status in stable COPD? Source: Eur Respir J 2006; 28: Suppl. 50, 163s Year: 2006 The relationship between bronchial inflammation and markers of disease progression in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003 IFNL3 polymorphisms are associated with COPD severity and outcomes Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 COPD phenotypes Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease Year: 2016 COPD phenotypes Source: International Congress 2015 – PG2 Asthma and COPD Year: 2015 Are COPD exacerbations associated with the severity of the disease? Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005 Metabolic changes in lung ageing and COPD Source: International Congress 2019 – Metabolic alterations in lung ageing and disease Year: 2019 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Beclin1 circulating levels and accelerated ageing markers in COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 COPD and comorbidity: common pathways of accelerated ageing Source: International Congress 2015 – China Day "Advances in pulmonology" I Year: 2015 ADAM33 SNPs are associated with excess FEV1 decline in severe early onset COPD Source: Eur Respir J 2006; 28: Suppl. 50, 582s Year: 2006 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018